|
BM51757 |
N',N'',2-Tris(5-chloro-2-hydroxybenzylidene)hydrazine-1-carbohydrazonhydrazide hydrochloride |
2408590-37-2 |
C22H18Cl4N6O3 |
556.2287 |
VIEW DETAILS > |
|
BM52439 |
Ethyl (S)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoate |
2230697-41-1 |
C30H34N4O6S |
578.6792 |
VIEW DETAILS > |
|
BM48952 |
2-{6-amino-5-[(1R,5S)-8-{2-[(1r,3r)-3-(piperidin-4-yloxy)cyclobutoxy]pyridin-4-yl}-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl}phenol, trans |
2378051-78-4 |
C30H37N7O3 |
543.6599 |
VIEW DETAILS > |
|
BM53264 |
4-[({1-[(tert-butoxy)carbonyl]pyrrolidin-3-yl}({[(9H-fluoren-9-yl)methoxy]carbonyl})amino)methyl]-1H-pyrrole-2-carboxylic acid |
2137548-68-4 |
C30H33N3O6 |
531.5995 |
VIEW DETAILS > |
|
BM57557 |
5′-Des-O-methylharringtonine |
182325-73-1 |
C27H35NO9 |
517.5681 |
VIEW DETAILS > |
|
BM57739 |
FAK-IN-2 |
2872588-02-6 |
C28H31ClN8O3 |
563.0505 |
VIEW DETAILS > |
|
BM57924 |
EIF2α activator 1 |
2851820-52-3 |
C25H19F6N3O3 |
523.4271 |
VIEW DETAILS > |
|
BM57805 |
h-NTPDase-IN-4 |
2939933-09-0 |
C22H8F12N2S |
560.3582 |
VIEW DETAILS > |
|
BM57941 |
USP7-IN-11 |
2763872-32-6 |
C29H27ClN6O2S |
559.0817 |
VIEW DETAILS > |
|
BM57976 |
3-{4-[(tert-butoxy)carbonyl]-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}piperazin-2-yl}benzoic acid |
2913406-46-7 |
C31H32N2O6 |
528.5956 |
VIEW DETAILS > |